DOCSLIB.ORG

WHO Tobacco Control Papers

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WHO Tobacco Control Papers UCSF WHO Tobacco Control Papers Title Report on Tobacco Control in India Permalink https://escholarship.org/uc/item/7231191t Authors WHO Ministry of Health & Family Welfare Government of India et al. Publication Date 2004-11-15 eScholarship.org Powered by the California Digital Library University of California Report on Tobacco Control in India Edited by K. Srinath Reddy Prakash C. Gupta This report is jointly supported by Ministry of Health & Family Welfare, Government of India Centers for Disease Control and Prevention, USA World Health Organization Tobacco Control in India Report on Tobacco Control in India (New Delhi, India), 25 November 2004 Ministry of Health & Family Welfare, Nirman Bhawan, Maulana Azad Road, New Delhi 110011, India Disclaimer: The views expressed in this report are not necessarily those of the Ministry of Health & Family Welfare, Government of India, who commissioned the report as well as the World Health Organization and Centers for Disease Control and Prevention (USA), who provided technical guidance. Preparation of this report has been jointly undertaken by HRIDAY, New Delhi, India and Tata Memorial Centre, Mumbai, India HRIDAY Tata Memorial Centre T-7, Green Park Extension Dr Ernest Borges Marg, Parel New Delhi 110016 Mumbai 400012 India up to 31 July 2004; since then Healis Sekhsaria Institute of Public Health 601, Great Eastern Chambers 6th Floor, Plot No. 28, Sector 11 CBD Belapur (E) Navi Mumbai 400614 India on behalf of Ministry of Health & Family Welfare, Government of India The report has been technically edited by BYWORD EDITORIAL CONSULTANTS A-217, Somdatt Chambers I, Bhikaiji Cama Place New Delhi 110066, India Printed at Shree Om Enterprises Pvt. Ltd., A-98/3 Okhla Industrial Area, Pahse II, New Delhi 110020 ii Tobacco Control in India Foreword Hkkjr ljdkj LokLF; ,oa ifjokj dY;k.k ea=ky; ubZ fnYyh & 110011 GOVERNMENT OF INDIA MINISTRY OF HEALTH & FAMILY WELFARE NEW DELHI - 110011 J.V.R. Prasada Rao Health Secretary Tobacco use is a serious public health challenge in several regions of the world. It has assumed the dimension of an epidemic resulting in enormous disability, disease and death. It is estimated that five million preventable deaths occur every year globally, attributable to tobacco use. At this rate, the number of such deaths is expected to double by 2020. In addition to damage to personal health, tobacco use results in severe societal costs like reduced productivity and health care burden, environmental damage and poverty of the families. The degree of destruction brought to bear upon the individual and society surpasses the returns generated by tobacco production and consumption in terms of revenue and employment. India has been very conscious of the harmful effects of tobacco use, disease burden and related social and economic costs of health care. Over the period, various administrative measures were taken to prohibit tobacco smoking in public places and regulate the sale of tobacco products and their advertisements. A serious need was felt for framing a comprehensive national legislation on tobacco control, which would ensure uniform and effective enforcement of measures to achieve desired results. After detailed deliberations, the Government of India enacted The Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act, 2003 in May 2003 with a view to protect public health by prohibiting smoking in public places, banning advertisements of the tobacco products, banning sale of tobacco products to minors and near educational institutions, prescribing strong health warnings including pictorial depiction on tobacco products and regulation of tar and nicotine contents of tobacco products. For any legislation to be successful there is a need for adequate preparedness on the part of civil society, locally and globally, with regard to awareness of the existing problem and acceptance of the necessity for such legal measures. At the global level, India has been a forerunner in the negotiations leading to the Framework Convention on Tobacco Control, which was ratified by India in February 2004. At the domestic level, the State Governments, which are the main implementing agencies, have been advised to enforce the provisions of the tobacco control legislation strictly. As a measure to sensitize members of civil society, policy-makers, parliamentarians, scientific and public health professionals, researchers and the general public, it was necessary to compile basic data and analysis of tobacco use in the country, the extent of disease burden, present status of tobacco control measures, global experience in this field and proposed road map for future course of planning and action. This report Tobacco Control in India has been commissioned with this purpose in view. This report is a product of the untiring efforts of the editors, Dr K. Srinath Reddy, Dr P.C. Gupta, their research teams and also the valuable contributions made by individual experts. The Centers for Disease Control and Prevention, Atlanta, USA extended all technical support during the entire period of report development. This publication, I am confident, will fulfil its purpose of raising the awareness among policy-makers, experts, activists and the public at large about the threat of tobacco use and its consequences, which impinges upon the health of the people of India and its economy. 5 November 2004 (J.V.R. Prasada Rao) iii Tobacco Control in India Preface This report owes its origins to the recent global surge in action against tobacco. As awareness of the dangers posed by tobacco spread, nations across the world resolved to forge a campaign strategy and frame a battle plan to overcome the tobacco threat. Indias anti-tobacco law emerged in April 2003, close to the closure of the intergovernmental negotiations on the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) in March 2003. Soon thereafter, the Ministry of Health and Family Welfare, Government of India (MOHFW), decided to commission a detailed review of the status of tobacco control in India. This was intended to collate the Indian experience and craft a plan for future action based on a critical appraisal of global evidence and Indias specific needs. The series of scientific reports published by the Surgeon General of the United States of America have served, over the years, as the best sources of evidence-based information on the adverse health effects of tobacco use and a resource for the best practices for tobacco use, prevention and control. The collaboration of the US Centers for Disease Control and Prevention (CDC) was, therefore, welcomed by MOHFW for the purpose of providing technical support to the development of this report. In order to engage the expertise and the energy of a wide range of experts, public health advocates and civil society representatives, MOHFW invited two Indian agencies which have been actively contributing to knowledge acquisition and public health action on issues relevant to tobacco control. As their representatives, we were given the privilege of compiling and editing this report. We undertook this task by inviting several Indian contributors, with specific expertise in different areas related to tobacco control, to contribute (individually and jointly) to different sections of defined chapters. Their manuscripts were extensively reviewed by other Indian and international experts and were later edited and integrated by us to form the text of this report. In undertaking the major task of bringing this report together, we were guided by an advisory group of public health experts from India and the United States. It is an interesting coincidence that the thread of history which originally brought tobacco to India from the Americas had now knit together public health experts from the two countries into a combined effort to advance the agenda of tobacco control and promote public health in India. The potential impact of such an undertaking ensures that children are protected from the social and cultural influences that lead to tobacco addiction, that all tobacco users are encouraged to quit, and that non-smokers are protected from second-hand smoke. This report provides a major source in our national efforts to prevent and control tobacco use. It is also intended to inform and assist many sections of our society who are committed to protecting Indias national interests by preserving and promoting the health of our people. Since several of such readers will not be health professionals, an attempt has been made to keep the language as free from technical jargon as possible. Most of the readers will know that tobacco is harmful but not how harmful. We hope this report will inform them. Many of our readers will want to control tobacco but not know how best to do it. We hope this report will aid them. Above all, we hope this report will provide policy-makers the necessary impetus to initiate and implement a coordinated comprehensive national strategy for tobacco control. K. SRINATH REDDY 15 November 2004 PRAKASH C. GUPTA iv Tobacco Control in India Acknowledgements Advisory Group SAMIRA ASMA ALTAF LAL Associate Director Science Section Global Tobacco Control Office on Smoking and US Embassy Health New Delhi Centers for Disease Control and Prevention Atlanta India USA VINEET GILL MUNISH DILEEP BAL National Professional Officer Chief, Cancer Control Branch Tobacco Free Initiative California Department of Health Services
Load more

Recommended publications
  • Question of the Day Archives: Monday, December 5, 2016 Question: Calcium Oxalate Is a Widespread Toxin Found in Many Species of Plants
    Question Of the Day Archives: Monday, December 5, 2016 Question: Calcium oxalate is a widespread toxin found in many species of plants. What is the needle shaped crystal containing calcium oxalate called and what is the compilation of these structures known as? Answer: The needle shaped plant-based crystals containing calcium oxalate are known as raphides. A compilation of raphides forms the structure known as an idioblast. (Lim CS et al. Atlas of select poisonous plants and mushrooms. 2016 Disease-a-Month 62(3):37-66) Friday, December 2, 2016 Question: Which oral chelating agent has been reported to cause transient increases in plasma ALT activity in some patients as well as rare instances of mucocutaneous skin reactions? Answer: Orally administered dimercaptosuccinic acid (DMSA) has been reported to cause transient increases in ALT activity as well as rare instances of mucocutaneous skin reactions. (Bradberry S et al. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. 2009 Q J Med 102:721-732) Thursday, December 1, 2016 Question: What is Clioquinol and why was it withdrawn from the market during the 1970s? Answer: According to the cited reference, “Between the 1950s and 1970s Clioquinol was used to treat and prevent intestinal parasitic disease [intestinal amebiasis].” “In the early 1970s Clioquinol was withdrawn from the market as an oral agent due to an association with sub-acute myelo-optic neuropathy (SMON) in Japanese patients. SMON is a syndrome that involves sensory and motor disturbances in the lower limbs as well as visual changes that are due to symmetrical demyelination of the lateral and posterior funiculi of the spinal cord, optic nerve, and peripheral nerves.
    [Show full text]
  • List of References Submitted During the Public Consultation
    Bibliography of the Sources Examined for the Opinion on the Addictiveness and Attractiveness of Tobacco Additives ACSCAN (American Cancer Society Cancer Action Network), American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, American Legacy Foundation. Submission to U.S. Food and Drug Administration re Docket No. FDA- 2010-N-0207, 2010; July 26. Available from: URL: http://www.tobaccofreekids.org/reports/fda/regulatory_docs/Comments%20to%20 FDA%20RFI%20re%20youth%20and%20minority%20marketing%207-26-10.pdf Adam T, McAughey J, McGrath C, Mocker C, Zimmermann R. Simultaneous on-line size and chemical analysis of gas phase and particulate phase of cigarette mainstream smoke. Anal Bioanal Chem 2009; 394:1193-203. Adam T, Mitschke S, Streibel T, Baker RR, Zimmermann R. Puff-by-puff resolved characterisation of cigarette mainstream smoke by single photon ionisation (SPI)- time-of-flight mass spectrometry (TOFMS): comparison of the 2R4F research cigarette and pure Burley, Virginia, Oriental and Maryland tobacco cigarettes. Anal Chim Acta. 2006 Jul 21;572(2):219-29. Epub 2006; May 22. Ahijevych K, Garrett BE. Menthol pharmacology and its potential impact on cigarette smoking behaviour. Nicotine Tob Res 2004; 6 Suppl 1:S17-28. Ahijevych K, Gillespie J, Demirci M, Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in black and white women. Pharmacol Biochem Behav 1996; 53:355-60. Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav 1999; 24:115-20. Akehurst BC Tobacco. Second edition. Tropical Agriculture Series. Longman. London and New York. 1981; Pp.
    [Show full text]
  • Tobacco in Australia Facts & Issues
    Tobacco in Australia Facts & Issues A comprehensive online resource tobaccoinaustralia.org.au Book excerpt List of chapters available at tobaccoinaustralia.org.au Introduction Chapter 1 Trends in the prevalence of smoking Chapter 2 Trends in tobacco consumption Chapter 3 The health effects of active smoking Chapter 4 The health effects of secondhand smoke Chapter 5 Factors influencing the uptake and prevention of smoking Chapter 6 Addiction Chapter 7 Smoking cessation Chapter 8 Tobacco use among Aboriginal peoples and Torres Strait Islanders Chapter 9 Smoking and social disadvantage Chapter 10 The tobacco industry in Australian society Chapter 11 Tobacco advertising and promotion Chapter 12 The construction and labelling of Australian cigarettes Chapter 13 The pricing and taxation of tobacco products in Australia Chapter 14 Social marketing and public education campaigns Chapter 15 Smokefree environments Chapter 16 Tobacco litigation in Australia Chapter 17 The economics of tobacco control Chapter 18 The WHO Framework Convention on Tobacco Control Appendix 1 Useful weblinks to tobacco resources Tobacco in Australia: Facts and Issues. Fourth Edition A comprehensive review of the major issues in smoking and health in Australia, compiled by Cancer Council Victoria. First edition published by ASH (Australia) Limited, Surry Hills, NSW, 1989 Second edition published by the Victorian Smoking and Health Program, Carlton South, Victoria (Quit Victoria), 1995 Third edition published by Cancer Council Victoria 2008 in electronic format only. ISBN number: 978-0-947283-76-6 Suggested citation: Scollo, MM and Winstanley, MH. Tobacco in Australia: Facts and issues. 4th edn. Melbourne: Cancer Council Victoria; 2012. Available from www.TobaccoInAustralia.org.au OR <Author(s) of relevant chapter section>, <Name of chapter section> in Scollo, MM and Winstanley, MH [editors].
    [Show full text]
  • Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD
    Current Awareness in Clinical Toxicology Editors: Damian Ballam MSc and Allister Vale MD March 2014 CURRENT AWARENESS PAPERS OF THE MONTH Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom. A report from the UK National Poisons Information Service Kamour A, James D, Spears R, Cooper G, Lupton DJ, Eddleston M, Thompson JP, Vale AJ, Thanacoody HKR, Hill SL, Thomas SHL. Clin Toxicol 2014; 52: 192-7. Objective To characterise the patterns of presentation, clinical effects and possible harms of acute toxicity following recreational use of alpha methyltryptamine (AMT) in the United Kingdom, as reported by health professionals to the National Poisons Information Service (NPIS) and to compare clinical effects with those reported after mephedrone use. Methods NPIS telephone enquiries and TOXBASE® user sessions, the NPIS online information database, related to AMT were reviewed from March 2009 to September 2013. Telephone enquiry data were compared with those for mephedrone, the recreational substance most frequently reported to the NPIS, collected over the same period. Results There were 63 telephone enquiries regarding AMT during the period of study, with no telephone enquiries in 2009 or 2010, 19 in 2011, 35 in 2012 and 9 in 2013 (up to September). Most patients were male (68%) with a median age of 20 years. The route of exposure was ingestion in 55, insufflation in 4 and unknown in 4 cases. Excluding those reporting co-exposures, clinical effects recorded more frequently in AMT (n = 55) compared with those of mephedrone (n = 488) users including acute mental health disturbances (66% vs.
    [Show full text]
  • A SMALL DOSE of TOXICOLOGY the Health Effects of Common Chemicals
    A SMALL DOSE OF TOXICOLOGY The Health Effects of Common Chemicals A SMALL DOSE OF TOXICOLOGY The Health Effects of Common Chemicals Steven G. Gilbert, PhD, DABT Director, Institute of Neurotoxicology and Neurological Disorders Seattle USA CRC PRESS Boca Raton London New York Washington, D.C. This edition published in the Taylor & Francis e-Library, 2005. “To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.” Library of Congress Cataloging-in-Publication Data Gilbert, Steven G., 1951- A small dose of toxicology / Steven G. Gilbert. p. cm. Includes bibliographical references and index. ISBN 0-415-31168-3 1. Toxicology—Popular works. I. Title. RA1213 .G54 2003 615.9—dc21 2003055232 This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage or retrieval system, without prior permission in writing from the publisher. The consent of CRC Press LLC does not extend to copying for general distribution, for promotion, for creating new works, or for resale. Specific permission must be obtained in writing from CRC Press LLC for such copying.
    [Show full text]
  • Underage Vaping Spikes in the North of England
    Underage vaping spikes in the north of England thebureauinvestigates.com/stories/2020-05-04/underage-vaping-spikes-in-north-of-england More than a fifth of 15-year-olds in Yorkshire and the Humber vape, according to NHS figures that suggest a stark north-south divide in underage vaping. The data – based on a survey of 13,000 children produced after inquiries by The Bureau – found that teenagers in Yorkshire were more than three times as likely to vape regularly as those in London. Vaping has long been understood as a powerful tool in helping smokers quit, but with big tobacco companies spending billions getting e-cigarettes to market there is concern among campaigners and activists that these products could get a new generation hooked on nicotine. In the US more than one in four high school students regularly vape. In the UK, Public Health England has consistently said that relatively few teenagers vape. However the Bureau's research suggests that national data figures fail to recognise local hotspots. The majority of 15-year-olds in Yorkshire and the Humber have tried e-cigarettes. Almost 10% vape at least once a week, and another 12% vape occasionally. Separate figures produced by councils in Yorkshire highlighted the potential risk of teen vaping “hotspots” hidden in the national figures. A survey of 1,800 pupils aged 14 and 15 in Calderdale, West Yorkshire, found that 11% vaped at least once a week. 1/4 The northwest of England also has significantly higher underage vaping rates than the south, with 6% of 15-year-olds vaping at least once a week.
    [Show full text]
  • Assessment of Urinary Cotinine As a Marker of Nicotine Absorption from Tobacco Leaves: a Study on Tobacco Farmers in Malaysia
    Journal of J Occup Health 2003; 45: 140–145 Occupational Health Assessment of Urinary Cotinine as a Marker of Nicotine Absorption from Tobacco Leaves: A Study on Tobacco Farmers in Malaysia Mayumi ONUKI1, Kazuhito YOKOYAMA1, 2, Kaoru KIMURA1, Hajime SATO 1, Rusli Bin NORDIN3, Lin NAING3, Yoko MORITA4, Tadashi SAKAI4, Yasuki KOBAYASHI1 and Shunichi ARAKI5 1Department of Public Health, Graduate School of Medicine, The University of Tokyo, 2Department of Public Health, School of Medicine, Mie University, Japan, 3Department of Community Medicine, School of Medical Sciences, University Sains Malaysia, Malaysia, 4Occupational Poisoning Center, Tokyo Rosai Hospital and 5National Institute of Industrial Health, Japan Abstract: Assessment of Urinary Cotinine as a 1970 among 68 tobacco farmers in Florida, USA, by Marker of Nicotine Absorption from Tobacco Weizenecker and Deal1) and was named by Stephen and Leaves: A Study on Tobacco Farmers in Malaysia: Gehlbach2). GTS is characterized by nausea, vomiting, Mayumi ONUKI, et al. Department of Public Health, weakness, prostration and dizziness, and occasionally by Graduate School of Medicine, The University of fluctuation in blood pressure or heart rate1–22). Headache, Tokyo—To assess dermal absorption of nicotine from increased salivation, abdominal cramps, difficulty in tobacco leaves in relation to Green Tobacco Sickness (GTS), urinary cotinine concentrations were measured breathing, abdominal pain, and diarrhea have also been 9–22) in 80 male tobacco-growing farmers and in 40 healthy reported in recent studies of GTS . As GTS symptoms males (controls) who did not handle wet tobacco leaves usually disappear rapidly (in 2–3 d), treatment is not in Kelantan, Malaysia. Among non-smokers, urinary always necessary, but symptoms are so severe in some cotinine levels in farmers were significantly higher than cases that administration of dimenhydrinate (an those of controls; farmers with urinary cotinine of 50 antihistaminic and antiemetic agent) is required7).
    [Show full text]
  • Environmental Ethics and Pollution by Tobacco
    IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT) e-ISSN: 2319-2402,p- ISSN: 2319-2399.Volume 11, Issue 3 Ver. III (Mar. 2017), PP 74-80 www.iosrjournals.org Environmental Ethics and Pollution by Tobacco Jyotsna Lal Ph.D *, Niranjan Swaroop , Associate Professor, Department of Chemistry, Christ Church P.G College. Kanpur. U.P. Assistant Professor, Department of Mathematics, Christ Church P.G College . Kanpur. U.P. Abstract: Burning tobacco is the main source of indoor pollution in the developed world. Tobacco smoke contains about 4,000 chemicals including carcinogens, irritants and toxic gases. Nicotine, benzene and benzo(a)pyrene. The gas phase includes carbon monoxide, ammonia, dimethylnitrosamine, formaldehyde, hydrogen cyanide and acrolein. Methyl bromide, an ozone-depleting chemical commonly used to fumigate the soil prior planting tobacco seedlings. Tobacco growers are susceptible to an occupational illness known as green tobacco sickness. This is caused by the absorption of nicotine through the skin from contact with wet tobacco leaves. Nicotine is a risk factor for oral cancer, adult periodontal diseases and congenital defects such as cleft lip and palate in children. Nicotine causes heart arteries to harden, tend to shrink, thickening of blood increases cholesterol deposition leading to heart attack. Smoking causes lung cancer. Breathing other people's smoke is called passive, involuntary or secondhand smoking. The non-smoker breathes "side stream" smoke from the burning tip of the cigarette and "mainstream" smoke that has been inhaled and then exhaled by the smoker. Second hand smoke (SHS) is a major source of indoor air pollution. I.
    [Show full text]
  • (SCENIHR), "Addictiveness and Attractiveness of Tobacco Additives
    G Scientific Committee on Emerging and Newly Identified Health Risks SCENIHR Addictiveness and Attractiveness of Tobacco Additives SCENIHR adopted this opinion by written procedure on 12 November 2010 Addictiveness and Attractiveness of Tobacco Additives About the Scientific Committees Three independent non-food Scientific Committees provide the Commission with the scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. They are: the Scientific Committee on Consumer Safety (SCCS), the Scientific Committee on Health and Environmental Risks (SCHER) and the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), and are made up of external experts. In addition, the Commission relies upon the work of the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), the European Centre for Disease prevention and Control (ECDC) and the European Chemicals Agency (ECHA). SCENIHR This Committee deals with questions related to emerging or newly identified health and environmental risks and on broad, complex or multidisciplinary issues requiring a comprehensive assessment of risks to consumer safety or public health and related issues not covered by other Community risk assessment bodies. Examples of potential areas of activity include potential risks associated with interaction of risk factors, synergic effects, cumulative effects, antimicrobial resistance, new technologies such as nanotechnologies, medical devices including those incorporating substances of animal and/or human origin, tissue engineering, blood products, fertility reduction, cancer of endocrine organs, physical hazards such as noise and electromagnetic fields (from mobile phones, transmitters and electronically controlled home environments), and methodologies for assessing new risks.
    [Show full text]
  • Green Tobacco Sickness
    N O R T H C A ROLINA FARMWORKER HEALTH MODULES GREEN TOBACCO SICKNESS N O R T H C A ROLINA FARMWORKER HEALTH MODULES GREEN TOBACCO SICKNESS Self Assessment/Pre-Test (to be completed before reading GTS content) 1. What is green tobacco sickness? a. symptoms caused by exposure of wet tobacco leaves to bare skin b. nicotine poisoning c. a preventable illness d. all of the above 2. What can be done to prevent green tobacco sickness? a. avoid working in tobacco just after a rain or while leaves are dewy b. cover bare skin and wear protective water-proof clothing c. change clothes after leaving the tobacco field, even if clothes are dry d. shower as soon as possible after leaving field e. all of the above 3. Which of the following is NOT a common symptom for green tobacco sickness? a. dizziness b. headache c. nausea d. vomiting e. skin rash 4. Is green tobacco sickness life-threatening? a. No, it is a serious condition but usually not deadly. b. Yes 5. Who is at risk of green tobacco sickness? a. only first-time workers in tobacco fields b. only workers over 65 years old c. anyone who works in tobacco fields d. only non-smokers 6. Which conditions make it more likely that someone will become sick from tobacco? a. long exposure to tobacco leaves b. individual sensitivity to tobacco c. wet leaves from dew or rain d. exposed skin e. all of the above 7. How often should a farmworker drink water during the day? a.
    [Show full text]
  • Tobacco Control for Sustainable Development Tobacco Control for Sustainable Development ISBN: 978-92-9022-578-2 © World Health Organization 2017 Some Rights Reserved
    Tobacco control for sustainable development Tobacco control for sustainable development ISBN: 978-92-9022-578-2 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.. Suggested citation. Tobacco control for sustainable development. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders.
    [Show full text]
  • Tobacco Science SITAB 38 2012
    Newsletter of The 38 Italian Society of Tobaccology 2012 www.tabaccologia.it 333 Tobacco Science Stan Bulletin, Smoking & Tobacco Abstracts & News. Update N. 1 3 Giugno 2012 Editor: Biagio Tinghino Editorial board : Massimo Baraldo, Fabio Beatrice, M aria Sofia Cattaruzza, Fabio Lugoboni, Giacomo Mangiaracina, Nolita Pulerà, Biagio Tinghino, Vincenzo Zagà, Francesca Zucchetta. In the News : • Australia: Customs Act Amendment: Harsher Penalties Proposed for Tobacco Smugglers • Australia: Metal cigarette packets: retailers could get burned • Canada: Alberta: Province set to launch $10-billion lawsuit against tobacco companies • Canada: MB/SK: Provinces pass enabling legislation for health care recovery tobacco lawsuits • Canada: Lancet Oncol: Budget cuts overshadow good news on cancer statistics • China: Health Hazards of Smoking: Landmark report calls for butting out • China: Shanghai: Health Promotion Commission Survey: Residents want smoking banned indoors • Israel: Number of adult smokers declines by 2.7 percent to record low • NZ: Tasmania: Smoke-free proposal stirs debate [Tob Control : Singapore: Phasing-out tobacco (2010) ] • Russia: Philip Morris, BAT, Japan Tobacco Battle Putin’s Anti-Smoking Plan • US: CA: Prop 29: Separating Fact From Fiction: Arguments for Yes Vote • US: California: Prop 29: Ad Blitz Ahead of Vote on Cigarette Tax • US: FL: Four tobacco companies ordered to pay more than $75 million to smoker's widow • US: MN: State Supreme Court ruling ends Marlboro Lights class-action lawsuit • US: NY: CLASH: Pro-tobacco lobby delays implementation of state park smoking ban • US/NZ: Washington Post: Editorial: Snuffing out tobacco with taxes? Noteworthy : "Documentation of such a high prevalence of TSE [Tobacco Smoke Exposure] in this population lends further support to public policies for smoke-free multiunit housing because poor and medically underserved populations disproportionately live in apartments.
    [Show full text]